HINT2 and metabolic dysfunction-associated steatotic liver disease: To investigate the function of HINT2 in MASLD, we induced metabolic dysfunction-associated steatotic liver (MASL), the early stage of MASLD, using ~12–16-week HFD feeding in mice.